Bosnia and Herzegovina vs Rwanda: Hepatitis B surface antigen (HBsAg) prevalence
Bosnia and Herzegovina
0.3%
in 2024
Rwanda
0.3%
in 2024
Bosnia and Herzegovina rank
71st
Rwanda rank
71st
Hepatitis B surface antigen (HBsAg) prevalence over time
- Bosnia and Herzegovina
- Rwanda
How they compare
Bosnia and Herzegovina currently reports 0.3% against 0.3% in Rwanda, a difference of 0.0%.
The two have swapped places 2 times across 10 shared years of data; in 2015 it was Rwanda ahead.
Bosnia and Herzegovina ranks 71st and Rwanda ranks 71st of 194 countries.
Bosnia and Herzegovina has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Bosnia and Herzegovina | Rwanda | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.3% | 0.3% | 0.0% | — |
| 2020s | 0.3% | 0.3% | 0.0% | Bosnia and Herzegovina |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hepatitis b surface antigen (hbsag) prevalence, Bosnia and Herzegovina or Rwanda?
- Bosnia and Herzegovina, at 0.3% against 0.3% in Rwanda as of 2024.
- What is the difference in hepatitis b surface antigen (hbsag) prevalence between Bosnia and Herzegovina and Rwanda?
- 0.0%, with Bosnia and Herzegovina ahead.
- How many years of comparable data are there for Bosnia and Herzegovina and Rwanda?
- 10 years are reported by both, from 2015 to 2024.
- How do Bosnia and Herzegovina and Rwanda rank globally for hepatitis b surface antigen (hbsag) prevalence?
- Bosnia and Herzegovina ranks 71st and Rwanda ranks 71st of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Hepatitis B surface antigen (HBsAg) prevalence (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.